Clinical Trials Sponsored by Navitas Pharma

Total 8362 results

Navitas Pharma
IndiPharm Inc.

Not yet recruiting

Cicletanine in Hypertension With Diabetes: Added Magnesium Preserves Potassium and Sodium (CHAMP)

Diabetes | Hyponatremia | Arterial Hypertension | Hypokalemia
NaviFUS Corporation
NaviFUS US LLC

Not yet recruiting

Safety and Efficacy of Bevacizumab in Combination With NaviFUS System for the Treatment of Recurrent Glioblastoma Multiforme (rGBM)

Glioma | Neoplasms | Glioblastoma | Neoplasms, Nerve Tissue | Brain Tumor | Glioblastoma Multiforme

United States
Nuritas Ltd

Recruiting

The Effects of PeptiStrong and Exercise to Enhance Muscle Strength in Young Subjects

Muscle Injury

Canada
NaviFUS Corporation

Recruiting

NaviFUS™ System Neuromodulating Treatment for Patients With Drug Resistant Epilepsy

Drug Resistant Epilepsy

Taiwan
NaviFUS Corporation

Recruiting

Evaluate the Safety and Preliminary Efficacy of the Combination of NaviFUS System With Re-irradiation for rGBM Patients

Recurrent Glioblastoma

Taiwan
Sanitas University

Unknown

Comparison Between the Right Lateral Decubitus and the Left Lateral Decubitus as Starting Position in Colonoscopy (POSCOL)

Colonoscopy

Colombia
Nuritas Ltd

Completed

Effects of Protein Hydrolysate Supplement on Systemic Muscle Function Markers Following Resistance Type Exercise in Male Subjects

Muscle Injury

Ireland
Sanitas University

Unknown

Efficacy of an Electronic System to Support Clinical Decisions in Adults With Type 2 Diabetes Mellitus. (OSI-DM)

Diabetes Mellitus, Type 2
Focused Ultrasound Foundation
Navitas Clinical Research, Inc

Terminated

Focused Ultrasound for the Treatment of Pancreatic Cancer - an International Registry (ARRAY)

Pancreatic Cancer

Taiwan, Korea, Republic of, Bulgaria, United Kingdom
Bayer
Navitas Life Sciences GmbH; LKF Laboratory

Completed

Efficacy of Gynodian® Depot in Women With Impaired Well-being

Hormone Replacement Therapy
Navitas Life Sciences GmbH
GE Healthcare; Bayer; Guerbet

Completed

Long-Term Retention of Gadolinium in Bone

Focus: Long-term Retention of Gadolinium-based Contrast Agent

Spain, Korea, Republic of, United States, Germany, Japan, Turkey
Gravitas Medical, Inc.

Recruiting

Entarik Feeding Tube System Placement in Adult ICU

Nasogastric Tube

United States
Gravitas Medical, Inc.

Recruiting

Gravitas Feeding Tube System Placement Validation in Neonates

Nasogastric Tube

United States
Gravitas Medical, Inc.

Completed

Gravitas Feeding Tube System Placement in Neonates

Nasogastric Tube

United States
Navitor Pharmaceuticals, Inc.

Completed

Safety, Tolerability, PK and Efficacy of Single Doses of NV-5138 in Healthy Volunteers and Subjects With Treatment-Resistant Depression

Treatment Resistant Depression

United States
Renew Research, LLC
Navitas Clinical Research, Inc; ClinEdge, LLC

Completed

Renew NCP-5 for the Treatment of Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild Dementia of the Alzheimer's Type

Cognitive Dysfunction | Alzheimer Disease | Mild Cognitive Impairment | Cognitive Decline | Dementia, Alzheimer Type | Mild Dementia

United States, Singapore, Ireland
Shenyang Sunshine Pharmaceutical Co., LTD.
Navitas Life Sciences GmbH

Terminated

Biosimilar Erythropoietin in Anaemia Treatment (Correction Phase Study) (BEAT_001)

Renal Anaemia

Thailand
Novita Pharmaceuticals, Inc.

Recruiting

NP-G2-044 as Monotherapy and Combination Therapy in Patients With Advanced or Metastatic Solid Tumor Malignancies

Advanced or Metastatic Solid Tumor Malignancies

United States
Davita Clinical Research

Completed

Registry of Sustained Immunity to COVID-19 Among ESKD Patients (RePAiR)

SARS-CoV-2 Infection | Anti-SARS-CoV-2 Infection

United States
Shenyang Sunshine Pharmaceutical Co., LTD.
Navitas Life Sciences GmbH

Completed

Biosimilar Erythropoietin in Anaemia Treatment (Maintenance Phase Study) (BEAT_002)

Renal Anemia

Thailand, Russian Federation
R-Pharm
Covance; Cromos Pharma LLC

Withdrawn

Study of the Efficacy and Safety of a Single Administration of Olokizumab vs. Placebo in Addition to Standard Treatment in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection (COVID-19).

COVID-19
Davita Clinical Research

Completed

COVID-19 Progression in End-Stage Kidney Disease (COPE)

SARS-CoV-2 Infection (Asymptomatic) | SARS-CoV-2 Infection (Symptomatic)

United States
Avita Medical

Completed

RECELL® System Combined With Meshed Autograft for Reduction of Donor Skin Harvesting in Soft Tissue Reconstruction

Cellulitis | Surgical Wound | Skin Cancer | Infection | Crush Injuries | Degloving Injuries | Gun Shot Wound | Necrotizing Fasciitis | Laceration of Skin | Full-thickness Skin Defects

United States
Avita Medical

Terminated

Feasibility Study to Evaluate RECELL and Melanocyte Keratinocyte Transplantation Procedure for Repigmentation of Stable Vitiligo Lesions

Vitiligo

United States
Claudia Aristizábal
Sanitas University

Completed

Non-immersive Virtual Reality for Pediatric Pain Management

Procedural Pain

Colombia
Genovate-NaviFUS (Australia) Pty Ltd.
Genovate Biotechnology Co., Ltd.,; NaviFUS Corporation

Recruiting

Evaluation of the NaviFUS System in Drug Resistant Epilepsy

Drug Resistant Epilepsy | Epilepsy, Temporal Lobe

Australia
Avita Medical

Active, not recruiting

Repigmentation of Stable Vitiligo Lesions Using Spray-On Skin™ Cells (TONE)

Vitiligo

United States
Avita Medical

Completed

CONTINUED ACCESS PROTOCOL: Demonstration of the Safety and Effectiveness of ReCell® Combined With Meshed Skin Graft for Reduction of Donor Area in the Treatment of Acute Burn Injuries

Burns

United States
Avita Medical

Completed

Prospective Evaluation of the ReCell® Autologous Cell Harvesting Device For Specific Compassionate Use Cases

Burns

United States
Avita Medical

Completed

A Feasibility Study of the ReGenerCell™ Autologous Cell Harvesting Device for Diabetic Foot Ulcers

Diabetic Foot Ulcer

United Kingdom
Avita Medical

Completed

Clinical Study to Investigate the Safety and Effectiveness of RECELL for Repigmentation of Stable Vitiligo Lesions

Vitiligo

United States
UCB BIOSCIENCES, Inc.
R-Pharm

Terminated

Open-label Study to Assess the Safety and Efficacy of CDP6038 (Olokizumab) in Patients Who Completed RA0056

Rheumatoid Arthritis

United States, Belgium, United Kingdom
AJU Pharm Co., Ltd.
OM Pharma SA

Recruiting

The Efficacy and Safety of OM-89 in Patients With Recurrent Chronic Prostatitis/Chronic Pelvic Pain Syndrome

Chronic Prostatitis With Chronic Pelvic Pain Syndrome | Chronic Prostatitis | Chronic Pelvic Pain Syndrome

Korea, Republic of
UCB BIOSCIENCES, Inc.
R-Pharm

Terminated

The Long-term Safety and Efficacy of CDP6038 (Olokizumab) With Active Rheumatoid Arthritis

Rheumatoid Arthritis

Japan, Korea, Republic of, Taiwan
Caritas Institute of Higher Education

Unknown

Effectiveness of Text Message-based Rehabilitation Program for Patients With Peripheral Artery Disease

Message-based Rehabilitation for Peripheral Artery Disease Patients

China, Hong Kong
Yuria-Pharm
Pharmaxi LLC

Completed

Epidemiological Study of the COVID-2019 in Participating Organizations.

Covid19

Ukraine
Avita Medical
NAMSA

Completed

A Pilot Trial of the Use of ReCell® Autologous Cell Harvesting Device for Venous Leg Ulcers

Venous Leg Ulcers

United Kingdom, France
TNO
Vitas; SwissAnalysis

Completed

Effects of Personalized Dietary Advice on Health Status of Diabetes Type 2 Patients (PDA(4)T2D)

Diabetes Mellitus, Type 2

Netherlands
Claudia Aristizábal
Universidad Nacional de Colombia; Universidad de Santander; Fundación Universitaria...

Enrolling by invitation

Efficacy of a Multicomponent and Interdisciplinary Intervention on the Care Ability and Burden of Family Caregivers of People With Chronic Cardiocerebrovascular Diseases (Emiicare)

Burnout, Psychological | Caregivers

Colombia
Navitor Pharmaceuticals, Inc.
Supernus Pharmaceuticals, Inc.

Recruiting

Phase 2 Study of NV-5138 in Adults With Treatment Resistant Depression

Treatment Resistant Depression

United States
Kavita Sarin
Medivir

Terminated

Topical Remetinostat Gel as Neoadjuvant Therapy in Patients With Squamous Cell Carcinoma (SCC)

Squamous Cell Carcinoma

United States
Nuritas Ltd
RDC Clinical Pty Ltd

Not yet recruiting

Effects of PeptiSleep in Healthy Males and Females With Mild to Moderate Sleep Impairment

Sleep
Navitor Pharmaceuticals, Inc.
Supernus Pharmaceuticals, Inc.

Recruiting

Open-Label of SPN-820 in Adults With Major Depressive Disorder

Major Depressive Disorder

United States
Nuritas Ltd
Atlantia Food Clinical Trials

Completed

Study to Evaluate Bioactive Peptides' Effect on Digestive Discomfort Symptoms of the Elderly (Inflammaging)

Abdominal Pain
NaviFUS Corporation
Chang Gung Memorial Hospital

Completed

Safety of BBB Disruption Using NaviFUS System in Recurrent Glioblastoma Multiforme (GBM) Patients

Glioma | Neoplasms | Glioblastoma | Neoplasms, Nerve Tissue | Brain Tumor | Glioblastoma Multiforme

Taiwan
NaviFUS Corporation
Chang Gung Memorial Hospital

Completed

Efficacy and Safety of NaviFUS System add-on Bevacizumab (BEV) in Recurrent GBM Patients

Glioma | Neoplasms | Glioblastoma | Neoplasms, Nerve Tissue | Brain Tumor | Glioblastoma Multiforme

Taiwan
Navitor Pharmaceuticals, Inc.
Supernus Pharmaceuticals, Inc.

Completed

Mass Balance Study of NV-5138 in Healthy Male Subjects.

Healthy Volunteers

United Kingdom
Davita Clinical Research
Abbott Nutrition

Completed

DaVita Assessment of Nutritional Supplement Effects (DANSE) (DANSE)

Malnutrition

United States
Trevi Therapeutics
Davita Clinical Research

Completed

Phase 1 Study of Nalbuphine HCl ER Tablets in Hemodialysis Patients With Uremic Pruritus

Uremic Pruritus
Namita Sood

Completed

Tricuspid Regurgitant Jet Velocity as an Independent Marker for Mortality in Sickle Cell Anemia

Sickle Cell Anemia | Pulmonary Hypertension

United States

Clinical Trials Sponsored by Navitas Pharma

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Guinea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations